(Q39428445)

11 September 2017

Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells (English)

1 reference

11 September 2017

0 references

Y Zhang

1

1 reference

11 September 2017

Y Ge

2

1 reference

11 September 2017

Y Chen

3

1 reference

11 September 2017

Q Li

4

1 reference

11 September 2017

J Chen

5

1 reference

11 September 2017

Y Dong

6

1 reference

11 September 2017

W Shi

7

1 reference

11 September 2017

13 December 2011

1 reference

Cell Biochemistry & Function

11 September 2017

1 reference

11 September 2017

30

1 reference

11 September 2017

3

1 reference

11 September 2017

243-248

1 reference

11 September 2017

Cancer statistics, 2009

1 reference

Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways

21 January 2018

1 reference

Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer

21 January 2018

1 reference

Silymarin: a review of its clinical properties in the management of hepatic disorders

21 January 2018

1 reference

Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells

21 January 2018

1 reference

Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages

21 January 2018

1 reference

Silibinin inhibits translation initiation: implications for anticancer therapy

21 January 2018

1 reference

Protective effects of silybin and analogues against X-ray radiation-induced damage

21 January 2018

1 reference

Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.

21 January 2018

1 reference

Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy

21 January 2018

1 reference

Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma

21 January 2018

1 reference

Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer

21 January 2018

1 reference

Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents

21 January 2018

1 reference

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

Cell-cycle targeted therapies

21 January 2018

1 reference

Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells

21 January 2018

1 reference

21 January 2018

1 reference

Shared pathways: death receptors and cytotoxic drugs in cancer therapy

21 January 2018

1 reference

Chemotherapy: targeting the mitochondrial cell death pathway

21 January 2018

1 reference

Induction of apoptosis by cancer chemotherapy.

21 January 2018

1 reference

Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/CBF.1842

1 reference

11 September 2017

1 reference